Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo

Introduction Malaria in pregnancy is a major driver of maternal and infant mortality in sub-Saharan Africa. The WHO recommends the administration of intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp-SP) at antenatal care (ANC) visits. Despite being a highly cost-effective strate...

Full description

Bibliographic Details
Published in:BMJ Global Health
Main Authors: Charfudin Sacoor, Martin Meremikwu, Laia Cirera, Clara Pons-Duran, Máximo Ramírez, Elaine Roman, Franco Pagnoni, Clara Menendez, Raquel González, Christina Maly, Elisa Sicuri, Dachi Arikpo, Manu F Manun’Ebo, Antía Figueroa-Romero, Louise Ranaivo, Francesco Ramponi
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Online Access:https://gh.bmj.com/content/8/7/e010238.full
_version_ 1851912064852819968
author Charfudin Sacoor
Martin Meremikwu
Laia Cirera
Clara Pons-Duran
Máximo Ramírez
Elaine Roman
Franco Pagnoni
Clara Menendez
Raquel González
Christina Maly
Elisa Sicuri
Dachi Arikpo
Manu F Manun’Ebo
Antía Figueroa-Romero
Louise Ranaivo
Francesco Ramponi
author_facet Charfudin Sacoor
Martin Meremikwu
Laia Cirera
Clara Pons-Duran
Máximo Ramírez
Elaine Roman
Franco Pagnoni
Clara Menendez
Raquel González
Christina Maly
Elisa Sicuri
Dachi Arikpo
Manu F Manun’Ebo
Antía Figueroa-Romero
Louise Ranaivo
Francesco Ramponi
author_sort Charfudin Sacoor
collection DOAJ
container_title BMJ Global Health
description Introduction Malaria in pregnancy is a major driver of maternal and infant mortality in sub-Saharan Africa. The WHO recommends the administration of intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp-SP) at antenatal care (ANC) visits. Despite being a highly cost-effective strategy, IPTp-SP coverage and uptake remains low. A pilot project was conducted to assess the cost-effectiveness (CE) of community-based delivery of IPTp (C-IPTp) in addition to ANC delivery to increase IPTp uptake in the Democratic Republic of Congo (DRC), Madagascar (MDG), Mozambique (MOZ) and Nigeria (NGA).Methods Costs and CE estimates of C-IPTp were calculated according to two scenarios: (1) costs in ‘programmatic mode’ (ie, costs if C-IPTp was to be implemented by national health systems) and (2) costs from the pilot project. The effectiveness of C-IPTp was obtained through estimates of the averted disability-adjusted life-years (DALYs) associated with maternal clinical malaria and anaemia, low birth weight and neonatal mortality.Results Net incremental costs of C-IPTp ranged between US$6138–US$47 177 (DRC), US$5552–US$31 552 (MDG), US$10 202–US$53 221 (MOZ) and US$667–US$28 645 (NGA) per 1000 pregnant women, under scenarios (1) and (2), respectively. Incremental cost-effectiveness ratios (ICERs) ranged between US$15–US$119 in DRC, US$9–US$53 in MDG, US$104–US$543 in MOZ and US$2–US$66 in NGA per DALY averted, under scenarios (1) and (2), respectively. ICERs fall below the WHO recommended CE threshold based on the gross domestic product per capita.Conclusion Findings suggest that C-IPTp is a highly cost-effective intervention. Results can inform policy decisions on adopting and optimising effective interventions for preventing malaria in pregnancy.
format Article
id doaj-art-cc2848cd2c2f4e69afabbe83a72f3ca1
institution Directory of Open Access Journals
issn 2059-7908
language English
publishDate 2023-07-01
publisher BMJ Publishing Group
record_format Article
spelling doaj-art-cc2848cd2c2f4e69afabbe83a72f3ca12025-08-19T22:01:33ZengBMJ Publishing GroupBMJ Global Health2059-79082023-07-018710.1136/bmjgh-2022-010238Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of CongoCharfudin Sacoor0Martin Meremikwu1Laia Cirera2Clara Pons-Duran3Máximo Ramírez4Elaine Roman5Franco Pagnoni6Clara Menendez7Raquel González8Christina Maly9Elisa Sicuri10Dachi Arikpo11Manu F Manun’Ebo12Antía Figueroa-Romero13Louise Ranaivo14Francesco Ramponi15Manhiça Health Research Center, Manhiça, MozambiqueCross River Health and Demographic Surveillance System, University of Calabar, Calabar, NigeriaMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainJhpiego, Johns Hopkins University Affiliate, Baltimore, Maryland, USAMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainManhiça Health Research Center, Manhiça, MozambiqueMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainJhpiego, Johns Hopkins University Affiliate, Baltimore, Maryland, USAMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainCross River Health and Demographic Surveillance System, University of Calabar, Calabar, NigeriaBureau d’Étude et de Gestion de l’Information Statistique (BEGIS), Kinshasa, Congo (the Democratic Republic of the)Maternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainMalagasy Associates for Numerical Information and Statistical Analysis (MANISA), Antananarivo, MadagascarMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainIntroduction Malaria in pregnancy is a major driver of maternal and infant mortality in sub-Saharan Africa. The WHO recommends the administration of intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp-SP) at antenatal care (ANC) visits. Despite being a highly cost-effective strategy, IPTp-SP coverage and uptake remains low. A pilot project was conducted to assess the cost-effectiveness (CE) of community-based delivery of IPTp (C-IPTp) in addition to ANC delivery to increase IPTp uptake in the Democratic Republic of Congo (DRC), Madagascar (MDG), Mozambique (MOZ) and Nigeria (NGA).Methods Costs and CE estimates of C-IPTp were calculated according to two scenarios: (1) costs in ‘programmatic mode’ (ie, costs if C-IPTp was to be implemented by national health systems) and (2) costs from the pilot project. The effectiveness of C-IPTp was obtained through estimates of the averted disability-adjusted life-years (DALYs) associated with maternal clinical malaria and anaemia, low birth weight and neonatal mortality.Results Net incremental costs of C-IPTp ranged between US$6138–US$47 177 (DRC), US$5552–US$31 552 (MDG), US$10 202–US$53 221 (MOZ) and US$667–US$28 645 (NGA) per 1000 pregnant women, under scenarios (1) and (2), respectively. Incremental cost-effectiveness ratios (ICERs) ranged between US$15–US$119 in DRC, US$9–US$53 in MDG, US$104–US$543 in MOZ and US$2–US$66 in NGA per DALY averted, under scenarios (1) and (2), respectively. ICERs fall below the WHO recommended CE threshold based on the gross domestic product per capita.Conclusion Findings suggest that C-IPTp is a highly cost-effective intervention. Results can inform policy decisions on adopting and optimising effective interventions for preventing malaria in pregnancy.https://gh.bmj.com/content/8/7/e010238.full
spellingShingle Charfudin Sacoor
Martin Meremikwu
Laia Cirera
Clara Pons-Duran
Máximo Ramírez
Elaine Roman
Franco Pagnoni
Clara Menendez
Raquel González
Christina Maly
Elisa Sicuri
Dachi Arikpo
Manu F Manun’Ebo
Antía Figueroa-Romero
Louise Ranaivo
Francesco Ramponi
Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo
title Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo
title_full Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo
title_fullStr Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo
title_full_unstemmed Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo
title_short Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo
title_sort cost effectiveness of community based distribution of intermittent preventive treatment of malaria in pregnancy in madagascar mozambique nigeria and the democratic republic of congo
url https://gh.bmj.com/content/8/7/e010238.full
work_keys_str_mv AT charfudinsacoor costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT martinmeremikwu costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT laiacirera costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT claraponsduran costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT maximoramirez costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT elaineroman costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT francopagnoni costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT claramenendez costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT raquelgonzalez costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT christinamaly costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT elisasicuri costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT dachiarikpo costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT manufmanunebo costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT antiafigueroaromero costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT louiseranaivo costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo
AT francescoramponi costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo